Related Experiment Video
Updated: Jan 8, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Developing a QSPR model for Alzheimer's drugs using topological indices and M-polynomial: A computational study
Mohammad Hadi Akhbari1, Fateme Movahedi2, Mahsa Zameni3
1Department of Mathematics, Es.C., Islamic Azad University, Estahban, Iran. hadi.akhbari@iau.ac.ir.
None:
Topological indices, which are numerical descriptors that encode molecular structure, are widely used in computational drug discovery due to their efficiency and interpretability. In this study, we developed a robust quantitative structure-property relationship (QSPR) framework to predict the core physicochemical properties of nine clinically relevant Alzheimer's disease drugs, including Donepezil, Galantamine, and Memantine. We employed a streamlined computational approach, using MATLAB and the M-polynomial method, to efficiently calculate a series of degree-based topological indices. Through comprehensive regression analyses, we identified strong correlations between degree-based topological indices and key physicochemical properties, including boiling point and molar refractivity. While linear models provided a reasonable baseline, nonlinear models, particularly cubic and power equations, delivered significantly improved predictive accuracy. The analysis highlighted the critical interplay between the choice of the index and the regression model. For instance, the cubic model was frequently the most effective for predicting properties such as boiling point and flash point, while the power model performed best for molar refractivity and polarizability. Notably, the redefined first Zagreb index and the modified first Zagreb index exhibited exceptional predictive capacity, reflecting their sensitivity to structural features that govern physicochemical behavior. The strong performance of these QSPR models underscores their potential to accelerate the rational design of Alzheimer's therapeutics. By enabling rapid, cost-effective, and reliable property prediction prior to synthesis, this framework offers a valuable tool for future drug development efforts.
More Related Videos
06:34Author Spotlight: Stimulation-Based Approach to Improve Cerebral Blood Flow in Alzheimer's Model
Published on: June 2, 2023
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...